2,5-Dimethoxy-4-isobutylamphetamine


2,5-Dimethoxy-4-isobutylamphetamine is a serotonin 5-HT2A receptor agonist, serotonergic psychedelic, and anti-inflammatory drug of the phenethylamine, amphetamine, and DOx families.

Use and effects

DOIB is active at doses of 10 to 15mg orally, and hence is about one-third as potent as DOM.

Pharmacology

DOIB is a full agonist of the serotonin 5-HT2A receptor, with an of 12.6nM and an of 98.8%, both for calcium mobilization. It is about one-third as potent as DOM in rodent drug discrimination tests and also substitutes for LSD in these tests. In addition to its psychedelic effects, DOIB has highly potent anti-inflammatory effects in preclinical research. It was more potent than almost any other tested psychedelic. The drug was notably more potent than (R)-DOI, but was less potent than 2C-I.

Chemistry

Analogues

DOIB is part of the series of straight-chain and branched-chain 4-alkylated DOx drugs that also includes DOM, DOET, DOPR, DOBU, DOAM, and DOHx, among others.
Some other notable analogues of DOIB include DOBU, DOSB, and DOTB.

Society and culture

Legal status

Canada

DOIB is a controlled substance in Canada under phenethylamine blanket-ban language.